Navidea Biopharmaceuticals PE Ratio 2010-2023 | NAVB
Current and historical p/e ratio for Navidea Biopharmaceuticals (NAVB) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Navidea Biopharmaceuticals PE ratio as of July 14, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Navidea Biopharmaceuticals PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-14 | 0.00 | 0.00 | |
| 2023-09-30 | 0.09 | $-0.06 | 0.00 |
| 2023-06-30 | 0.09 | $-0.29 | 0.00 |
| 2023-03-31 | 0.26 | $-0.51 | 0.00 |
| 2022-12-31 | 0.21 | $-0.56 | 0.00 |
| 2022-09-30 | 0.25 | $-0.57 | 0.00 |
| 2022-06-30 | 0.72 | $-0.40 | 0.00 |
| 2022-03-31 | 0.79 | $-0.39 | 0.00 |
| 2021-12-31 | 1.00 | $-0.40 | 0.00 |
| 2021-09-30 | 1.75 | $-0.39 | 0.00 |
| 2021-06-30 | 1.83 | $-0.44 | 0.00 |
| 2021-03-31 | 2.02 | $-0.46 | 0.00 |
| 2020-12-31 | 2.15 | $-0.48 | 0.00 |
| 2020-09-30 | 2.70 | $-0.52 | 0.00 |
| 2020-06-30 | 3.94 | $-0.56 | 0.00 |
| 2020-03-31 | 0.76 | $-0.69 | 0.00 |
| 2019-12-31 | 1.26 | $-0.80 | 0.00 |
| 2019-09-30 | 0.69 | $-1.05 | 0.00 |
| 2019-06-30 | 0.63 | $-1.28 | 0.00 |
| 2019-03-31 | 2.76 | $-1.44 | 0.00 |
| 2018-12-31 | 2.05 | $-2.00 | 0.00 |
| 2018-09-30 | 4.61 | $-2.20 | 0.00 |
| 2018-06-30 | 4.57 | $-2.00 | 0.00 |
| 2018-03-31 | 7.20 | $-2.20 | 0.00 |
| 2017-12-31 | 7.17 | $9.00 | 0.80 |
| 2017-09-30 | 8.30 | $9.20 | 0.90 |
| 2017-06-30 | 10.20 | $9.40 | 1.09 |
| 2017-03-31 | 11.53 | $9.20 | 1.25 |
| 2016-12-31 | 12.75 | $-1.60 | 0.00 |
| 2016-09-30 | 18.31 | $-1.60 | 0.00 |
| 2016-06-30 | 10.61 | $-2.60 | 0.00 |
| 2016-03-31 | 18.89 | $-3.00 | 0.00 |
| 2015-12-31 | 26.60 | $-3.60 | 0.00 |
| 2015-09-30 | 45.60 | $-4.20 | 0.00 |
| 2015-06-30 | 32.20 | $-4.20 | 0.00 |
| 2015-03-31 | 31.80 | $-4.40 | 0.00 |
| 2014-12-31 | 37.80 | $-5.00 | 0.00 |
| 2014-09-30 | 26.40 | $-6.00 | 0.00 |
| 2014-06-30 | 29.60 | $-6.80 | 0.00 |
| 2014-03-31 | 37.00 | $-7.20 | 0.00 |
| 2013-12-31 | 41.40 | $-6.80 | 0.00 |
| 2013-09-30 | 53.00 | $-6.20 | 0.00 |
| 2013-06-30 | 53.40 | $-6.20 | 0.00 |
| 2013-03-31 | 54.20 | $-5.60 | 0.00 |
| 2012-12-31 | 56.60 | $-5.80 | 0.00 |
| 2012-09-30 | 55.00 | $-6.00 | 0.00 |
| 2012-06-30 | 74.40 | $0.00 | 0.00 |
| 2012-03-31 | 65.60 | $0.80 | 82.00 |
| 2011-12-31 | 52.40 | $1.20 | 43.67 |
| 2011-09-30 | 59.20 | $2.20 | 26.91 |
| 2011-06-30 | 66.40 | $-2.60 | 0.00 |
| 2011-03-31 | 79.00 | $-15.00 | 0.00 |
| 2010-12-31 | 41.20 | $-14.60 | 0.00 |
| 2010-09-30 | 37.60 | $-14.00 | 0.00 |
| 2010-06-30 | 36.00 | $-20.20 | 0.00 |
| 2010-03-31 | 32.80 | $-11.60 | 0.00 |
| 2009-12-31 | 24.40 | $-10.80 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $185.102B | 81.07 |
| Thermo Fisher Scientific (TMO) | United States | $160.563B | 19.42 |
| Edwards Lifesciences (EW) | United States | $45.919B | 30.11 |
| Alcon (ALC) | Switzerland | $43.070B | 29.11 |
| IDEXX Laboratories (IDXX) | United States | $42.738B | 49.12 |
| DexCom (DXCM) | United States | $33.459B | 51.72 |
| IQVIA Holdings (IQV) | United States | $27.702B | 15.52 |
| Mettler-Toledo (MTD) | United States | $24.812B | 29.51 |
| STERIS (STE) | Ireland | $22.211B | 24.46 |
| Waters (WAT) | United States | $18.101B | 25.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.184B | 0.00 |
| Hologic (HOLX) | United States | $14.400B | 15.65 |
| Sysmex ADR (SSMXY) | Japan | $10.569B | 29.98 |
| Penumbra (PEN) | United States | $9.268B | 72.74 |
| Masimo (MASI) | United States | $8.767B | 32.34 |
| Globus Medical (GMED) | United States | $7.767B | 18.51 |
| Glaukos (GKOS) | United States | $5.953B | 0.00 |
| Teleflex (TFX) | United States | $5.115B | 8.44 |
| Integer Holdings (ITGR) | United States | $4.169B | 21.84 |
| TransMedics (TMDX) | United States | $3.953B | 85.94 |
| PROCEPT BioRobotics (PRCT) | United States | $3.218B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.398B | 14.28 |
| Nihon Kohden (NHNKY) | Japan | $2.099B | 24.07 |
| Veracyte (VCYT) | United States | $2.087B | 29.29 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Alphatec Holdings (ATEC) | United States | $1.595B | 0.00 |
| Artivion (AORT) | United States | $1.353B | 126.72 |
| Pulse Biosciences (PLSE) | United States | $1.081B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.049B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.949B | 5.05 |
| IRadimed (IRMD) | United States | $0.738B | 37.47 |
| SiBone (SIBN) | United States | $0.738B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.619B | 13.42 |
| Beta Bionics (BBNX) | United States | $0.556B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.548B | 8.53 |
| AxoGen (AXGN) | United States | $0.547B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.456B | 10.60 |
| Pacific Biosciences Of California (PACB) | United States | $0.438B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.413B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.391B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.332B | 0.00 |
| RxSight (RXST) | United States | $0.315B | 0.00 |
| NeuroPace (NPCE) | United States | $0.313B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.274B | 0.00 |
| Neuronetics (STIM) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.241B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.14 |
| Monogram Orthopaedics (MGRM) | United States | $0.209B | 0.00 |
| CVRx (CVRX) | United States | $0.192B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Inogen (INGN) | United States | $0.180B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.179B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.149B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.075B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 43.20 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.056B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 22.22 |
| Vicarious Surgical (RBOT) | United States | $0.054B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.023B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.51 |